Valeant Stock Shows Signs Of Life After ValueAct Buy

Published: Mar 17, 2017

Valeant shares were soaring after the market's close Thursday on news that ValueAct Capital purchased three million more share in the embattled biotech.

Valeant shares were up 5.5% after hours and continuing to climb. At time of writing, shares were at $11.82 apiece.

ValueAct currently holds a 4.39% stake in Valeant, according to FactSet. It is the second largest shareholder in the company, following Paulson & Co. Inc., which holds a 5.68% stake.

Back to news